Welcome to our dedicated page for Barron's 400 ETF news (Ticker: BFOR), a resource for investors and traders seeking the latest updates and insights on Barron's 400 ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Barron's 400 ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Barron's 400 ETF's position in the market.
The Barron's 400 ETF (BFOR) underwent a semi-annual reconstitution on September 17, 2021, replacing 175 of its constituents, slightly above the historical turnover of 42.2%. This adjustment highlights a preference for large-cap healthcare stocks, including Regeneron and Moderna, while decreasing the technology sector's representation to the lowest in two years. The rebalancing reflects a growing focus on cyclical sectors and signals a robust economic recovery, with 34 new companies joining the index. BFOR remains committed to selecting stocks based on strong financial fundamentals.
The Barron's 400 ETF (BFOR) completed its semi-annual reconstitution on March 19, 2021, replacing 167 stocks, slightly below the historical average of 42.2%. This shift reflects a significant increase in Consumer Discretionary stocks, while Industrials saw a decline. Noteworthy additions include major tech companies like Intel and Cisco. Since the last rebalance, BFOR gained 32%, outperforming the Russell 3000 Index, which rose by 20%. The average MarketGrader score of retained companies is 68.2, indicating improved fundamental health within the index.
FAQ
What is the current stock price of Barron's 400 ETF (BFOR)?
